Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
160 participants
INTERVENTIONAL
2019-08-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sensory Memory in Speech Motor Learning
NCT04818268
Speech Motor Learning and Retention (Aim 3)
NCT06492252
Somesthesic Role of the Ventro-lateral Prefrontal Cortex in Speech Motor Learning
NCT04547569
Sensory-motor Interactions in the Perception of Vowels: a Study in Repetition - Suppression
NCT03102983
Left and Right Hemisphere Contributions to Speech Perception
NCT04989309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adaptation to Altered Sensory Feedback + cTBS to S1
Adaptation to Altered Sensory Feedback + cTBS to S1
Adaptation
Sensorimotor adaptation in speech
cTBS
continuous theta-burst stimulation
Adaptation to Altered Sensory Feedback + cTBS to A1
Adaptation to Altered Sensory Feedback + cTBS to A1
Adaptation
Sensorimotor adaptation in speech
cTBS
continuous theta-burst stimulation
Adaptation to Altered Sensory Feedback + cTBS to M1
Adaptation to Altered Sensory Feedback + cTBS to M1
Adaptation
Sensorimotor adaptation in speech
cTBS
continuous theta-burst stimulation
Adaptation to Altered Sensory Feedback + Sham cTBS
Adaptation to Altered Sensory Feedback + Sham cTBS
Adaptation
Sensorimotor adaptation in speech
cTBS
continuous theta-burst stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adaptation
Sensorimotor adaptation in speech
cTBS
continuous theta-burst stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no known physical or neurological abnormalities
Exclusion Criteria
* cardiac pacemaker
* surgical clips or values on the heart
* implants
* metal or metallic fragments in any part of the body
* pregnancy
* claustrophobia
* a personal or family history of epilepsy
* currently taking antipsychotic drugs
* currently taking antidepressant drugs
* currently taking antianxiety drugs
* history of concussion.
21 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University
OTHER
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Ostry
Role: PRINCIPAL_INVESTIGATOR
Haskins Laboratories
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McGill University
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000025475
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.